SmarterDx

SmarterDx

Analyzes medical data to support diagnoses

Overview

SmarterDx analyzes medical data from patient charts to support faster, data-driven clinical decisions. It uses counterfactual modeling to identify missed Clinical Documentation Improvement (CDI) and coding opportunities, helping providers improve patient care and increase revenue. The platform processes diverse data points such as notes, lab results, medications, orders, vitals, and ICD-10 codes, turning slow, manual searches into rapid, informed decisions. Unlike traditional approaches, SmarterDx emphasizes surfacing missed opportunities in documentation and coding, and offers a risk-free business model with a guaranteed 5:1 return on investment, aiming to streamline workflows, enhance patient care, and boost revenue for healthcare providers.

About SmarterDx

Simplify's Rating
Why SmarterDx is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

201-500

Company Stage

Series B

Total Funding

$56M

Headquarters

New York City, New York

Founded

2020

Get referred to SmarterDx

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • SmarterDx reported 85+ health systems and 300+ hospital sites on September 3, 2026.
  • SmarterDenials launched March 16, 2025, expanding revenue capture beyond pre-bill review.
  • New Mountain's April 17, 2025 growth investment funds product innovation and commercial expansion.

What critics are saying

  • New Mountain acquired SmarterDx in May 2025, risking roadmap changes and cross-sell pressure.
  • Indeed reviews on April 30, 2026 describe cuts, brutal workloads, and management churn.
  • Waystar/Iodine, Regard, and Ambience increasingly bundle adjacent workflows, shrinking standalone differentiation.

What makes SmarterDx unique

  • Physician-built counterfactual modeling reviews every discharge chart, not sample audits.
  • SmarterDx understands 10,000 diagnoses and procedures, sharpening missed-CDI detection.
  • Black Book 2026 ranked SmarterDx third in acute-care evidence traceability.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$56M

Above

Industry Average

Funded Over

2 Rounds

Notable Investors:
Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Above Average

Industry standards

$35M
$45M
Linktree
$50M
SmarterDx
$65M
Substack
$100M
ClickUp

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Free One Medical membership

Parental Leave

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

0%

2 year growth

10%
PYMNTS
May 25th, 2025
Can Ai-Powered Smart Glasses Help Spot Medication Errors?

Every day, someone dies from getting the wrong medication or improper dosages of the right one. Now, researchers at the University of Washington (UW) are working on ways to solve this problem in part by using artificial intelligence (AI), NBC News reported Sunday (May 25). Dr. Kelly Michaelsen, an assistant professor of anesthesiology and pain medicine, told the network she had read studies at the prevalence of medication errors among anesthesiologists and began to wonder if AI could help spot errors

PR Newswire
May 13th, 2025
Smarterdx Named "Best Overall Healthcare Operations Solution" In 9Th Annual Medtech Breakthrough Awards Program

Prestigious international annual awards program recognizes standout digital health and medical technology products and companies.NEW YORK, May 8, 2025 /PRNewswire/ -- SmarterDx, the leader in clinical AI for revenue integrity and care quality, announced today that it has been selected as winner of the "Best Overall Healthcare Operations Solution" award in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market

JD Supra
Apr 30th, 2025
New Mountain Invests in SmarterDx AI

New Mountain Capital has made a strategic investment in SmarterDx, a New York-based company specializing in clinical AI for revenue integrity and care quality. New Mountain, also based in New York, is a growth-focused investment firm managing approximately $55 billion in assets. The terms of the investment were not disclosed.

FinSMEs
Apr 15th, 2025
SmarterDx Gains Investment from New Mountain

SmarterDx, a NYC-based clinical AI company, received an undisclosed investment from New Mountain Capital. The funds will support growth and product innovation. Founded in 2020, SmarterDx provides a platform to help hospitals analyze discharges and improve revenue integrity. Its solutions, SmarterPrebill™ and SmarterDenials™, assist in recovering revenue and improving care quality. Over 40 health systems with 180 hospital sites use its platform.

Health Technology Insights
Apr 14th, 2025
SmarterDx Begins Growth Phase with New Mountain Capital

SmarterDx, Inc., a leader in clinical AI for revenue integrity and care quality, announced a strategic investment from New Mountain Capital, LLC, a leading growth-oriented investment firm with more than $55 billion in assets under management.

Recently Posted Jobs

Sign up to get curated job recommendations

SmarterDx is Hiring for 12 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →